Aveo Pharmaceuticals, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

275,892

Value ($000)

4,124

Weight

0.0%

2020 Q1 - 2022 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	4,124	0.0%	275,892	12/31/2022
2022 Q3	11/14/2022	2,208	0.0%	268,314	9/30/2022
2022 Q2	8/12/2022	1,862	0.0%	283,969	6/30/2022
2022 Q1	5/13/2022	1,501	0.0%	268,684	3/31/2022
2021 Q4	2/11/2022	1,215	0.0%	259,065	12/31/2021
2021 Q3	11/12/2021	1,544	0.0%	249,969	9/30/2021
2021 Q2	8/13/2021	1,618	0.0%	245,645	6/30/2021
2021 Q1	5/12/2021	2,912	0.0%	397,937	3/31/2021
2020 Q4	2/12/2021	1,850	0.0%	320,675	12/31/2020
2020 Q3	11/13/2020	1,649	0.0%	277,771	9/30/2020
2020 Q2	8/13/2020	1,004	0.0%	195,026	6/30/2020
2020 Q1	5/14/2020	353	0.0%	97,599	3/31/2020